Detection and Possible Prognostic Relevance ofp53Gene Mutations in Diffuse Large B-cell Lymphoma. An Analysis of 51 Cases and Review of the Literature
- 1 October 2004
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (10) , 2071-2078
- https://doi.org/10.1080/10428190410001713170
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Although the presence of p53 gene mutations has been considered as a bad prognostic feature in DLBCL, its clinical significance is still controversial. the aims of this study were: detect the presence of mutations in exons 5 to 9 of the p53 gene and correlate it to prognosis in DLBCL. Fifty-one DLBCL patients were enrolled in this study. Expression of p53 was evaluated by immunohistochemistry. the screening of p53 mutations was performed using PCR-SSCP methods. Cases showing a mobility shift on SSCP electrophoresis were analyzed by automatic sequencing. We could identify 8 missense mutations in 6 of 48 cases (12.5%). in addition, we found a known polymorphism at codon 213 and 2 instances of silent mutations. of all mutations/polymorphisms found, 7 (64%) were localized in codons previously described as p53 hot spots in NHL cases. of the remaining alterations (4 or 36%), 2 mutations were localized in codons previously described as hot spots for p53 in other tumors and 2 (codon 142 of the exon 5 and codon 195 of the exon 6), in codons not described as hot spots for p53 up to now. the presence of missense mutations in exons 5 to 9 of p53 gene had adverse impact on overall survival (P=0.020). Cox's Regression Model identified that high-risk International Prognostic Index (IPI) and p53 gene mutations have independent negative impact on OS. Therefore, the association of IPI with cellular factors, such as p53 mutation, can be very helpful in deciding when we should indicate more aggressive therapies in patients with DLBCL, to somehow increase the chance of cure in these patients.Universidade Federal de São Paulo, UNIFESP EPM, Discipline Hematol & Hemotherapy, São Paulo, BrazilUniv Estadual Campinas, Hemoctr UNICAMP, São Paulo, BrazilUniversidade Federal de São Paulo, UNIFESP EPM, Dept Pathol, São Paulo, BrazilCtr Biol Mol Estrutural, Lab Nacl Luz Sincrotron, São Paulo, BrazilUniversidade Federal de São Paulo, UNIFESP EPM, Discipline Hematol & Hemotherapy, São Paulo, BrazilUniversidade Federal de São Paulo, UNIFESP EPM, Dept Pathol, São Paulo, BrazilWeb of SciencKeywords
This publication has 13 references indexed in Scilit:
- p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomasAnnals of Oncology, 2002
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathwaysBlood, 2002
- Crystal Structure of the Mouse p53 Core DNA-binding Domain at 2.7 Å ResolutionJournal of Biological Chemistry, 2001
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Correlation Between Mutation in P53, p53 Expression, Cytogenetics, Histologic Type, and Survival in Patients With B-Cell Non-Hodgkin's LymphomaBlood, 1997
- Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell LymphomaNew England Journal of Medicine, 1997
- p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON-HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONSThe Journal of Pathology, 1997
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958